We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » EMA Spells Out Disclosure Policy for Clinical Data Set for Publication
EMA Spells Out Disclosure Policy for Clinical Data Set for Publication
Drugmakers submitting anonymized clinical data in applications to the EMA must keep up on technology advances that could put that data at risk for re-identification.
To View This Article:
Login
Subscribe To International Pharmaceutical Regulatory Monitor